Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage.
Market Cap | 213.33 Million | Shares Outstanding | 41.025 Million | Avg 30-day Volume | 202.955 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.28 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -49.045 Million |
Price to Book Value | 0.9301 | Operating Margin | 0.0 | Enterprise Value | -17.266 Million |
Current Ratio | 16.406 | EPS Growth | -1.019 | Quick Ratio | 15.994 |
1 Yr BETA | 1.319 | 52-week High/Low | 10.97 / 3.17 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -54.9979 | Altman Z-Score | 10.0296 | Free Cash Flow to Firm | -30.332 Million |
Earnings Report | 2023-08-14 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
MEISNER DEREK M CHIEF LEGAL OFFICE & CORP SEC |
|
147,600 | 2023-01-17 | 3 |
ZUGA MATT CFO AND CHIEF BUSINESS OFFICER |
|
260,487 | 2023-01-17 | 2 |
OCONNELL DANIEL JOSEPH PRESIDENT AND CEO |
|
589,185 | 2023-01-17 | 1 |
SIEMERS ERIC CHIEF MEDICAL OFFICER |
|
146,900 | 2023-01-17 | 1 |
BARTON RUSSELL CHIEF OPERATING OFFICER |
|
146,900 | 2023-01-17 | 1 |
|
0 | 2023-01-04 | 2 | |
|
25,000 | 2022-06-15 | 1 | |
|
25,000 | 2022-06-15 | 1 | |
|
25,000 | 2022-06-15 | 1 | |
|
25,000 | 2022-06-15 | 1 | |
|
25,000 | 2022-06-15 | 1 | |
|
25,000 | 2022-06-15 | 1 | |
|
25,000 | 2022-06-15 | 1 | |
|
No longer subject to file | 2021-07-06 | 0 | |
|
No longer subject to file | 2021-07-06 | 0 | |
SANDS CAPITAL VENTURES DISCOVERY FUND III, L.P. SANDS CAPITAL GLOBAL VENTURE FUND II, L.P. |
|
No longer subject to file | 2021-07-06 | 0 |
HAYASHI SCOTT CHIEF FINANCIAL OFFICER |
|
6,923 | 2007-04-23 | 0 |
|
25,000 | 2007-01-16 | 0 | |
|
20,000 | 2007-01-11 | 0 | |
|
20,000 | 2007-01-11 | 0 | |
SEOH THOMAS C |
|
25,000 | 2007-01-11 | 0 |
|
30,000 | 2007-01-11 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-07 13:45:03 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-07 13:15:04 UTC | 0.3617 | 4.7083 | 350000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-07 12:45:04 UTC | 0.3617 | 4.7083 | 350000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 22:15:03 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 21:45:05 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 21:15:04 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 20:45:04 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 20:15:04 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 19:45:04 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 19:15:03 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 18:45:04 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 18:15:04 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 17:45:04 UTC | 0.3617 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 17:15:04 UTC | 0.3617 | 4.7083 | 350000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 16:45:04 UTC | 0.3517 | 4.7083 | 350000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 16:15:03 UTC | 0.3517 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 15:45:04 UTC | 0.3517 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 15:15:04 UTC | 0.3517 | 4.7083 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 14:45:04 UTC | 0.0112 | 5.0488 | 300000 |
ACUMEN PHARMACEUTICALS INC ABOS | 2023-06-06 14:15:03 UTC | 0.0112 | 5.0488 | 350000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|